Who Fills The Gap After OpenEvidence Left Europe (Philippe Habets, EvidenceHunt)

Faces of Digital Health by Tjasa Zajc

OpenEvidence didn't leave Europe because of regulation alone — its ad-and-data business model never fit the European market. When OpenEvidence, the $12B clinical AI search platform used daily by over 40% of US physicians...View more